Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 434 $ 1,554
Marketable debt securities, available for sale 926 6,687
Escrow receivable 4,812 4,830
Accounts receivable, net 2,010 2,968
Inventory 1,459 1,903
Prepaid expenses and other current assets 304 296
Total current assets 9,945 18,238
Property, plant and equipment, net of accumulated depreciation of $6,252 and $5,854, respectively 2,329 2,499
TOTAL ASSETS 12,274 20,737
Current liabilities    
Accounts payable 432 437
Accrued advertising and other allowances 92 101
Dividend payable 2,929
Other current liabilities 409 766
Total current liabilities 933 4,233
Non-current liabilities:    
Deferred revenue, net of current portion 110
Total non-current liabilities 110
Total liabilities 1,043 4,233
COMMITMENTS AND CONTINGENCIES
Stockholders' equity    
Preferred stock authorized 1,000,000, $.0005 par value, no shares issued
Common stock authorized 50,000,000, $.0005 par value, issued 28,225,615 and 28,201,541 shares, respectively 14 14
Additional paid-in capital 60,215 59,471
Retained earnings (accumulated deficit) (1,506) 4,533
Treasury stock, at cost, 16,652,022 and 16,652,022 shares (47,490) (47,490)
Accumulated comprehensive loss (2) (24)
Total stockholders' equity 11,231 16,504
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 12,274 $ 20,737